デフォルト表紙
市場調査レポート
商品コード
1608062

免疫健康サプリメント市場:製品、形態、供給源、投薬形態、流通チャネル別-2025-2030年世界予測

Immune Health Supplements Market by Products (Herbal Supplements, Probiotic Supplements, Vitamin & Mineral Supplements), Form (Capsules, Gel, Liquid), Source, Mode of Medication, Distribution Channel - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 180 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
免疫健康サプリメント市場:製品、形態、供給源、投薬形態、流通チャネル別-2025-2030年世界予測
出版日: 2024年10月31日
発行: 360iResearch
ページ情報: 英文 180 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

免疫健康サプリメント市場の2023年の市場規模は617億1,000万米ドルで、2024年には673億9,000万米ドルに達すると予測され、CAGR 8.02%で成長し、2030年には1,059億4,000万米ドルに達すると予測されています。

免疫健康サプリメント市場には、身体の自然な免疫防御を強化またはサポートするように設計された製品が含まれます。これには、免疫機能を強化することを目的としたビタミン、ミネラル、ハーブエキス、その他の成分が含まれます。健康意識の高まり、慢性疾患の罹患率の増加、特にCOVID-19の大流行を踏まえた予防医療への関心の高まりに影響され、免疫健康サプリメントの必要性が高まっています。用途は広範囲に及び、錠剤、粉末、グミなど様々な形態で、乳幼児、成人、高齢者など多様なエンドユーザーに提供され、消費者の嗜好に対応しています。市場の成長を促す主な要因としては、世界の高齢化人口の急増、サプリメント製剤の進歩、ヘルスケア支出の増加などが挙げられます。特筆すべきは、座りがちなライフスタイルと貧しい食習慣を持つ都市人口の増加が、こうした栄養補助食品の需要に大きく寄与していることです。アジア太平洋とラテンアメリカの新興市場は人口が多く、可処分所得が増加しているため、地理的拡大には大きな可能性があります。このような機会を活用するため、企業は、天然製品に対する消費者の需要の高まりに対応するため、クリーンラベルの成分や植物由来の処方を用いた革新的な製品の開発に注力すべきです。しかし、市場は厳しい規制、製品処方の難しさ、製品の有効性と安全性に対する消費者の懐疑心といった課題にも直面しています。こうした問題に対処するためには、ラベル表示の完全な透明化と強固なマーケティング戦略が推奨されます。個別化栄養学と腸管免疫軸に関する調査は、有望な技術革新の道筋を示すものです。全体として、免疫サプリメント市場はダイナミックで競争が激しく、成功のためには継続的な研究開発と戦略的ポジショニングが必要です。顧客教育の強化、医療専門家との共同イノベーション、デジタルヘルスソリューションへの投資は、この進化する情勢における成長と消費者の信頼をさらに促進することができます。

主な市場の統計
基準年[2023] 617億1,000万米ドル
推定年[2024] 673億9,000万米ドル
予測年[2030] 1,059億4,000万米ドル
CAGR(%) 8.02%

市場力学:急速に進化する免疫健康サプリメント市場の主要市場インサイトを公開

免疫健康サプリメント市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • 感染症、糖尿病、その他の疾患の有病率の増加
    • 体の免疫力を向上させるサプリメントの利用が世界的に急増
    • オンラインチャネルを通じた入手の増加
  • 市場抑制要因
    • 免疫サプリメント製品の高コスト
  • 市場機会
    • オーガニック免疫健康サプリメントの人気の高まり
    • 効果の高いサプリメントの研究開発活動の活発化
  • 市場の課題
    • 免疫健康サプリメントの副作用

ポーターのファイブフォース:免疫健康サプリメント市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:免疫健康サプリメント市場における外部からの影響の把握

外部マクロ環境要因は、免疫健康サプリメント市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析免疫健康サプリメント市場における競合情勢の把握

免疫健康サプリメント市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス免疫健康サプリメント市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、免疫健康サプリメント市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨免疫健康サプリメント市場における成功への道筋を描く

免疫健康サプリメント市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています:

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度:新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化:最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています:

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、セグメント、地域はどこか?

3.市場を形成する主な技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 感染症、糖尿病、その他の疾患の増加
      • 身体の免疫力を高めるサプリメントの利用が世界中で急増
      • オンラインチャネルを通じて可用性を高める
    • 抑制要因
      • 免疫健康サプリメント製品の高コスト
    • 機会
      • オーガニックの人気が高まっている免疫健康サプリメント
      • 効果の高いサプリメントの免疫健康サプリメントに関する研究開発活動の拡大
    • 課題
      • 免疫健康サプリメントの悪影響
  • 市場セグメンテーション分析
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治的
    • 経済
    • 社交
    • 技術的
    • 法律上
    • 環境

第6章 免疫健康サプリメント市場:製品別

  • ハーブサプリメント
    • マルチビタミン
    • セレンサプリメント
    • ビタミンB複合体サプリメント
    • ビタミンCサプリメント
    • ビタミンDサプリメント
    • 亜鉛サプリメント
  • プロバイオティクスサプリメント
  • ビタミン・ミネラルサプリメント

第7章 免疫健康サプリメント市場:形態別

  • カプセル
  • ゲル
  • 液体
  • ソフトジェル
  • タブレット

第8章 免疫健康サプリメント市場:ソース別

  • 動物由来
  • 植物由来

第9章 免疫健康サプリメント市場投薬方法別

  • 処方箋に基づく
  • セルフメディケーション

第10章 免疫健康サプリメント市場:流通チャネル別

  • オンラインストア
  • 薬局/ドラッグストア
  • 専門店
  • スーパーマーケットとハイパーマーケット

第11章 南北アメリカの免疫健康サプリメント市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第12章 アジア太平洋地域の免疫健康サプリメント市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第13章 欧州・中東・アフリカの免疫健康サプリメント市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第14章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
  • 戦略分析と提言

企業一覧

  • Abbott Laboratories
  • American Health Inc. by The Bountiful Company
  • Amway Corp.
  • Bayer AG
  • BioGaia AB
  • Blackmores Limited
  • Boehringer Ingelheim Pharma GmbH & Co. KG
  • GlaxoSmithKline PLC
  • Herbalife International of America, Inc.
  • Himalaya Wellness
  • Koninklijke DSM N.V.
  • Nestle S.A.
  • NOW Health Group, Inc.
  • Nutramax Laboratories, Inc.
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Limited
図表

LIST OF FIGURES

  • FIGURE 1. IMMUNE HEALTH SUPPLEMENTS MARKET RESEARCH PROCESS
  • FIGURE 2. IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. IMMUNE HEALTH SUPPLEMENTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. IMMUNE HEALTH SUPPLEMENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. IMMUNE HEALTH SUPPLEMENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. IMMUNE HEALTH SUPPLEMENTS MARKET DYNAMICS
  • TABLE 7. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MULTIVITAMINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SELENIUM SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY VITAMIN B COMPLEX SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY VITAMIN C SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY VITAMIN D SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ZINC SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PROBIOTIC SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY VITAMIN & MINERAL SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOFTGELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ANIMAL-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PLANT-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRESCRIPTION BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SELF-MEDICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PHARMACIES/DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SPECIALITY STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 97. INDIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 103. INDONESIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. INDONESIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 109. JAPAN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 110. JAPAN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 115. MALAYSIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. MALAYSIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 122. PHILIPPINES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 127. SINGAPORE IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SINGAPORE IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH KOREA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 139. TAIWAN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. TAIWAN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 145. THAILAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 146. THAILAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 151. VIETNAM IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 152. VIETNAM IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 164. DENMARK IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 165. DENMARK IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 170. EGYPT IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 171. EGYPT IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 176. FINLAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 177. FINLAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 182. FRANCE IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 183. FRANCE IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 188. GERMANY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 189. GERMANY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 194. ISRAEL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 195. ISRAEL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 200. ITALY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 201. ITALY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 206. NETHERLANDS IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 212. NIGERIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 213. NIGERIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 218. NORWAY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 219. NORWAY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 224. POLAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 225. POLAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 230. QATAR IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 231. QATAR IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 236. RUSSIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 237. RUSSIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 242. SAUDI ARABIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 248. SOUTH AFRICA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 254. SPAIN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 255. SPAIN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 260. SWEDEN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 261. SWEDEN IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 266. SWITZERLAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 271. TURKEY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 272. TURKEY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 273. TURKEY IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 284. UNITED KINGDOM IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY MODE OF MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM IMMUNE HEALTH SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 286. IMMUNE HEALTH SUPPLEMENTS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 287. IMMUNE HEALTH SUPPLEMENTS MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-02026C4CA4EE

The Immune Health Supplements Market was valued at USD 61.71 billion in 2023, expected to reach USD 67.39 billion in 2024, and is projected to grow at a CAGR of 8.02%, to USD 105.94 billion by 2030.

The immune health supplements market encompasses products designed to enhance or support the body's natural immune defenses. This includes vitamins, minerals, herbal extracts, and other ingredients aimed at bolstering immune function. The necessity for immune health supplements has grown, influenced by rising health awareness, increased incidence of chronic diseases, and a heightened focus on preventive healthcare, particularly in light of the COVID-19 pandemic. Applications are widespread, serving diverse end users such as infants, adults, and the elderly, in varied forms like tablets, powders, and gummies, thus catering to personalized consumer preferences. Key factors driving market growth include a burgeoning aging population globally, advancements in supplement formulations, and growing healthcare expenditure. Notably, the increasing urban population with a sedentary lifestyle and poor dietary habits is contributing significantly to the demand for these supplements. There is immense potential in geographical expansion, with emerging markets in Asia-Pacific and Latin America offering substantial opportunities due to their large population bases and rising disposable incomes. To tap into these opportunities, companies should focus on creating innovative products with clean-label ingredients and plant-based formulas to meet the growing consumer demand for natural products. However, the market also faces challenges, such as stringent regulations, product formulation difficulties, and consumer skepticism regarding product efficacy and safety. Full transparency in labeling and robust marketing strategies are recommended to address these issues. Research into personalized nutrition and the gut-immune axis represents promising innovation avenues. Overall, the immune health supplement market is dynamic and competitive, requiring ongoing R&D and strategic positioning to succeed. Enhanced customer education, collaborative innovation with healthcare professionals, and investment in digital health solutions can further drive growth and consumer trust in this evolving landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 61.71 billion
Estimated Year [2024] USD 67.39 billion
Forecast Year [2030] USD 105.94 billion
CAGR (%) 8.02%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Immune Health Supplements Market

The Immune Health Supplements Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of infectious diseases, diabetes, and several other disorders
    • Rapidly rising supplement utilization to improve the body's immunity globally
    • Increasing availability through online channels
  • Market Restraints
    • High cost of immune health supplement products
  • Market Opportunities
    • Prominent popularity of organic immune health supplements
    • Growing R&D activities on immune health supplements for highly effective supplements
  • Market Challenges
    • Adverse effects of immune health supplements

Porter's Five Forces: A Strategic Tool for Navigating the Immune Health Supplements Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Immune Health Supplements Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Immune Health Supplements Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Immune Health Supplements Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Immune Health Supplements Market

A detailed market share analysis in the Immune Health Supplements Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Immune Health Supplements Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Immune Health Supplements Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Immune Health Supplements Market

A strategic analysis of the Immune Health Supplements Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Immune Health Supplements Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, American Health Inc. by The Bountiful Company, Amway Corp., Bayer AG, BioGaia AB, Blackmores Limited, Boehringer Ingelheim Pharma GmbH & Co. KG, GlaxoSmithKline PLC, Herbalife International of America, Inc., Himalaya Wellness, Koninklijke DSM N.V., Nestle S.A., NOW Health Group, Inc., Nutramax Laboratories, Inc., Pfizer Inc., and Sun Pharmaceutical Industries Limited.

Market Segmentation & Coverage

This research report categorizes the Immune Health Supplements Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Products, market is studied across Herbal Supplements, Probiotic Supplements, and Vitamin & Mineral Supplements. The Herbal Supplements is further studied across Multivitamins, Selenium Supplements, Vitamin B complex Supplements, Vitamin C Supplements, Vitamin D Supplements, and Zinc Supplements.
  • Based on Form, market is studied across Capsules, Gel, Liquid, Powder, Softgels, and Tablets.
  • Based on Source, market is studied across Animal-Based and Plant-Based.
  • Based on Mode of Medication, market is studied across Prescription Based and Self-Medication.
  • Based on Distribution Channel, market is studied across Online Stores, Pharmacies/Drug Stores, Speciality Stores, and Supermarkets & Hypermarkets.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of infectious diseases, diabetes, and several other disorders
      • 5.1.1.2. Rapidly rising supplement utilization to improve the body's immunity globally
      • 5.1.1.3. Increasing availability through online channels
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of immune health supplement products
    • 5.1.3. Opportunities
      • 5.1.3.1. Prominent popularity of organic immune health supplements
      • 5.1.3.2. Growing R&D activities on immune health supplements for highly effective supplements
    • 5.1.4. Challenges
      • 5.1.4.1. Adverse effects of immune health supplements
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Immune Health Supplements Market, by Products

  • 6.1. Introduction
  • 6.2. Herbal Supplements
    • 6.2.1. Multivitamins
    • 6.2.2. Selenium Supplements
    • 6.2.3. Vitamin B complex Supplements
    • 6.2.4. Vitamin C Supplements
    • 6.2.5. Vitamin D Supplements
    • 6.2.6. Zinc Supplements
  • 6.3. Probiotic Supplements
  • 6.4. Vitamin & Mineral Supplements

7. Immune Health Supplements Market, by Form

  • 7.1. Introduction
  • 7.2. Capsules
  • 7.3. Gel
  • 7.4. Liquid
  • 7.5. Powder
  • 7.6. Softgels
  • 7.7. Tablets

8. Immune Health Supplements Market, by Source

  • 8.1. Introduction
  • 8.2. Animal-Based
  • 8.3. Plant-Based

9. Immune Health Supplements Market, by Mode of Medication

  • 9.1. Introduction
  • 9.2. Prescription Based
  • 9.3. Self-Medication

10. Immune Health Supplements Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Online Stores
  • 10.3. Pharmacies/Drug Stores
  • 10.4. Speciality Stores
  • 10.5. Supermarkets & Hypermarkets

11. Americas Immune Health Supplements Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Immune Health Supplements Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Immune Health Supplements Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. American Health Inc. by The Bountiful Company
  • 3. Amway Corp.
  • 4. Bayer AG
  • 5. BioGaia AB
  • 6. Blackmores Limited
  • 7. Boehringer Ingelheim Pharma GmbH & Co. KG
  • 8. GlaxoSmithKline PLC
  • 9. Herbalife International of America, Inc.
  • 10. Himalaya Wellness
  • 11. Koninklijke DSM N.V.
  • 12. Nestle S.A.
  • 13. NOW Health Group, Inc.
  • 14. Nutramax Laboratories, Inc.
  • 15. Pfizer Inc.
  • 16. Sun Pharmaceutical Industries Limited